Tohru Sugimoto - Publications, H-index & Citations

Tohru Sugimoto

Kyoto Prefectural University of Medicine

38H指数

300论文数

4.7K被引数

收录论文 36

发表时间

A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines

CANCER LETTERS

IF10.1

2013-04-01

PREAI

Sugimoto, Tohru; Gotoh, Takahiro; Yagyu, Sigeki; Kuroda, Hiroshi; Iehara, Tomoko; Hosoi, Hajime; Ohta, Sigeru; Ohira, Miki; Nakagawara, Akira

Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?

EUROPEAN JOURNAL OF CANCER

IF7.1

2012-07-01

OAAI

Iehara, Tomoko; Hiyama, Eiso; Tajiri, Tatsuro; Yoneda, Akihiro; Hamazaki, Minoru; Fukuzawa, Masahiro; Hosoi, Hajime; Sugimoto, Tohru; Sawada, Tadashi

Molecular dynamics simulations for glutamate-binding and cleft-closing processes of the ligand-binding domain of GluR2

BIOPHYSICAL CHEMISTRY

IF2.2

2012-03-01

PREAI

Okada, Okimasa; Odai, Kei; Sugimoto, Tohru; Ito, Etsuro

Preoperative analysis of 11q loss using circulating tumor-released DNA in serum: A novel diagnostic tool for therapy stratification of neuroblastoma

CANCER LETTERS

IF10.1

2011-10-01

PREAI

Yagyu, Shigeki; Iehara, Tomoko; Gotoh, Takahiro; Miyachi, Mitsuru; Katsumi, Yoshiki; Kikuchi, Ken; Tsuchiya, Kunihiko; Osone, Shinya; Kuroda, Hiroshi; Sugimoto, Tohru; Sawada, Tadashi; Hosoi, Hajime

Identification of therapy-sensitive and therapy-resistant neuroblastoma subtypes in stages III, IVs and IV

CANCER LETTERS

IF10.1

2011-07-01

PREAI

Kyo, Yohko; Tanaka, Takeo; Hayashi, Kunihiko; Iehara, Tomoko; Kaneko, Michio; Hosoi, Hajime; Sugimoto, Tohru; Hamasaki, Minoru; Kobayashi, Masao; Sawada, Tadashi

Lysosomal-associated protein multispanning transmembrane 5 gene (LAPTM5) is associated with spontaneous regression of neuroblastomas

CANCER RESEARCH

IF16.6

2010-04-01

PREAI

Inoue, Jun; Misawa, Akiko; Tanaka, Yukichi; Ichinose, Shizuko; Sugino, Yuriko; Hosoi, Hajime; Sugimoto, Tohru; Mato, Issei; Inazawa, Johji

Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice

MOLECULAR BRAIN

IF2.9

2009-06-18

108

OAAI

Tanda, Koichi; Nishi, Akinori; Matsuo, Naoki; Nakanishi, Kazuo; Yamasaki, Nobuyuki; Sugimoto, Tohru; Toyama, Keiko; Takao, Keizo; Miyakawa, Tsuyoshi

RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker 神经母细胞瘤患者预处理血清DNA中RASSF1A高甲基化: 预后标志物

BRITISH JOURNAL OF CANCER

IF6.8

2009-01-22

OAAI

Misawa, A.; Tanaka, S.; Yagyu, S.; Tsuchiya, K.; Iehara, T.; Sugimoto, T.; Hosoi, H.

Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma

CLINICAL CANCER RESEARCH

IF10.2

2008-11-03

OAAI

Yagyu, Shigeki; Gotoh, Takahiro; Iehara, Tomoko; Miyachi, Mitsuru; Katsumi, Yoshiki; Tsubai-Shimizu, Satoko; Kikuchi, Ken; Tamura, Shinichi; Tsuchiya, Kunihiko; Imamura, Toshihiko; Misawa-Furihata, Akiko; Sugimoto, Tohru; Sawada, Tadashi; Hosoi, Hajime

Fiber-tracking techniques can predict the degree of neurologic impairment for periventricular leukomalacia

PEDIATRICS

IF6.4

2008-09-01

PREAI

Murakami, Aki; Morimoto, Masafumi; Yamada, Kei; Kizu, Osamu; Nishimura, Akira; Nishimura, Tsunehiko; Sugimoto, Tohru

Trastuzumab activates allogeneic or autologous antibody-dependent cellular cytotoxicity against malignant rhabdoid tumor cells and interleukin-2 augments the cytotoxicity

CLINICAL CANCER RESEARCH

IF10.2

2008-02-15

OAAI

Katsumi, Yoshiki; Kuwahara, Yasumichi; Tamura, Shinichi; Kikuchi, Ken; Otabe, Osamu; Tsuchiya, Kunihiko; Iehara, Tomoko; Kuroda, Hiroshi; Hosoi, Hajime; Sugimoto, Tohru

Serum levels of MYCN amplification in neuroblastoma with tumor-released DNA by real-time quantitative polymerase chain reaction

PEDIATRICS

IF6.4

2008-01-01

PREAI

Sugimoto, Tohru; Gotoh, Takahiro; Iehara, Tomoko; Tsuchiya, Kunihiko; Ohira, Miki; Nakagawara, Akira; Hosoi, Hajime

Association of transforming growth factor-β1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases

HAEMATOLOGICA

IF7.9

2007-11-01

OAAI

Hatta, Kanako; Morimoto, Akira; Ishii, Eiichi; Kimura, Hiroshi; Ueda, Ikuyo; Hibi, Shigeyoshi; Todo, Shinjiro; Sugimoto, Tohru; Imashuku, Shinsaku

Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas

ONCOGENE

IF7.3

2007-05-28

PREAI

Sugino, Y.; Misawa, A.; Inoue, J.; Kitagawa, M.; Hosoi, H.; Sugimoto, T.; Imoto, I.; Inazawa, J.

SCN1A mutation mosaicism in a family with severe myoclonic epilepsy in infancy

EPILEPSIA

IF6.6

2006-10-18

OAAI

Morimoto, Masafumi; Mazaki, Emi; Nishimura, Akira; Chiyonobu, Tomohiro; Sawai, Yasuko; Murakami, Aki; Nakamura, Keiko; Inoue, Ikuyo; Ogiwara, Ikuo; Sugimoto, Tohru; Yamakawa, Kazuhiro

MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening

BRITISH JOURNAL OF CANCER

IF6.8

2006-05-02

OAAI

Iehara, T.; Hosoi, H.; Akazawa, K.; Matsumoto, Y.; Yamamoto, K.; Suita, S.; Tajiri, T.; Kusafuka, T.; Hiyama, E.; Kaneko, M.; Sasaki, F.; Sugimoto, T.; Sawada, T.

Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification

CANCER RESEARCH

IF16.6

2005-11-15

OAAI

Misawa, A; Inoue, J; Sugino, Y; Hosoi, H; Sugimoto, T; Hosoda, F; Ohki, N; Imoto, I; Inazawa, J

Diversity in neuroblastomas and discrimination of the risk to progress

CANCER LETTERS

IF10.1

2005-10-01

PREAI

Tanaka, T; Iehara, T; Sugimoto, T; Hamasaki, M; Teramukai, S; Tsuchida, Y; Kaneko, M; Sawada, T